Backed by GV.
About the role
Reporting to the Executive Director, Global Commercial Development – Pancreatic Cancer, this role will lead global commercial strategy and lifecycle development for the pancreatic cancer portfolio. This job description is across numerous positions, including daraxonrasib and zoldonrasib and future pipeline candidates, supporting opportunities in first-line metastatic, locally advanced, perioperative, and adjuvant disease, as well as future indications. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Bachelor’s degree with at least 15 years, or advanced degree with at least 8 years, of progressive commercial experience in a biotechnology and/or pharmaceutical company, including strategic marketing and ideally sales
- Proven success developing global oncology commercial strategies across products, indications, or stages of disease and influencing complex cross-functional product teams
- Demonstrated ability to develop patient and revenue forecasts, interpret market and clinical insights, and evaluate strategic trade-offs that inform portfolio investment decisions
- Strong leadership, ability to build high-performing teams and partnerships, and ability to influence without direct authority
- Excellent organizational and prioritization skills and the ability to deliver high-quality strategic work under evolving timelines
- Strong clinical and scientific acumen, ability to translate emerging clinical evidence, trial design, and oncology treatment pathways into commercial implications
More about this role
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
Reporting to the Executive Director, Global Commercial Development – Pancreatic Cancer, this role will lead global commercial strategy and lifecycle development for the pancreatic cancer portfolio. This job description is across numerous positions, including daraxonrasib and zoldonrasib and future pipeline candidates, supporting opportunities in first-line metastatic, locally advanced,...
Browse similar: Startup jobs · Remote jobs